Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001692444-26-000006

Director sold 599 shares at $80.11 ($47,986)

  • Director acquired 599 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Soteropoulos Paula Director 2026-03-31 Option exercise 10b5-1 +599 $8.44 $5,056 599 D
Soteropoulos Paula Director 2026-03-31 Sale 10b5-1 −599 $80.11 $47,986 0 D
Derivatives
Soteropoulos Paula Director 2026-03-31 Option exercise · Stock Option (Right to Buy) 10b5-1 −599 599 D
Open-market sales · 599 sh · avg $80.11 · $47,986
Loading xslF345X06/ownership.xml…